Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abbott Enhances Expertise in Information Management with STARLIMS Acquisition

By LabMedica International staff writers
Posted on 21 Dec 2009
Abbott (Abbott Park, IL, USA) has signed an agreement to acquire STARLIMS Technologies Ltd. More...
(Tel Aviv, Israel), a provider of laboratory information-management systems, for approximately U.S. $123 million in cash. The acquisition strengthens Abbott's competitive position in the global diagnostics market, providing advanced web-based applications to help laboratories efficiently store, retrieve, and analyze clinical, managerial, and administrative data.

STARLIMS' web-based technologies will help Abbott customers to operate efficiently across the core laboratory, molecular, and point-of-care segments of the global diagnostics market. As the company is integrated into Abbott's existing portfolio of laboratory information-management products, STARLIMS will continue to support and expand the nonclinical market segments it currently serves.

"We believe our laboratory information management solutions, which are widely used by government, manufacturing and life sciences organizations, have important applications in clinical laboratories for improving the access, exchange and analysis of patient and technical data," said Itschak Friedman, CEO of STARLIMS, who will continue to lead the STARLIMS team after the acquisition closes.

Advanced informatics systems are becoming increasingly important to clinical laboratories as a means to automate the retrieval, communication, and management of medical and laboratory data and aid compliance with global regulatory and industry standards. Informatics systems help laboratories to improve their operating efficiency through process standardization, reduced labor costs, and increased capacity. Improved laboratory operations benefit physicians and patients through improved turnaround times and more consistent interpretation of test results.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of pharmaceutics and medical products, including diagnostics, devices, and nutritionals.

STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing, and life sciences organizations. The company's flagship product, STARLIMS improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities.

Related Links:

Abbott
STARLIMS Technologies Ltd.



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.